Mark S. Nestor

3.2k total citations · 1 hit paper
105 papers, 2.1k citations indexed

About

Mark S. Nestor is a scholar working on Dermatology, Neurology and Epidemiology. According to data from OpenAlex, Mark S. Nestor has authored 105 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Dermatology, 32 papers in Neurology and 23 papers in Epidemiology. Recurrent topics in Mark S. Nestor's work include Botulinum Toxin and Related Neurological Disorders (30 papers), Facial Rejuvenation and Surgery Techniques (25 papers) and Dermatologic Treatments and Research (23 papers). Mark S. Nestor is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (30 papers), Facial Rejuvenation and Surgery Techniques (25 papers) and Dermatologic Treatments and Research (23 papers). Mark S. Nestor collaborates with scholars based in United States, Netherlands and United Kingdom. Mark S. Nestor's co-authors include Robert Y. Foos, Jay S. Pepose, Glynis Ablon, Alistair J. Cochran, Gary N. Holland, Daniel L. Fischer, Haowei Han, Anita Gade, Brian Berman and Michael H. Gold and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Ophthalmology.

In The Last Decade

Mark S. Nestor

94 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics

2021 209 citations Mark S. Nestor, Anita Gade et al. Journal of Cosmetic Dermatology profile →

Peers

Mark S. Nestor

DERMA

NEURO

EPIDE

OPHTH

SURGE

J. Mazereeuw‐Hautier France

Dale R. Meyer United States

Joel L. Cohen United States

Derek Jones United States

Henning Hamm Germany

Christopher B. Zachary United States

Georgi Tchernev Bulgaria

John Harper United Kingdom

F. Boralévi France

Seiji Kawana Japan

J. Mazereeuw‐Hautier France

Mark S. Nestor

1.0k ×1.1

DERMA

449 ×0.8

NEURO

316 ×0.7

EPIDE

62 ×0.2

OPHTH

951 ×3.8

SURGE

Citations per year, relative to Mark S. Nestor Mark S. Nestor (= 1×) peers J. Mazereeuw‐Hautier

Countries citing papers authored by Mark S. Nestor

Since Specialization

Citations

This map shows the geographic impact of Mark S. Nestor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Nestor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Nestor more than expected).

Fields of papers citing papers by Mark S. Nestor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Nestor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Nestor. The network helps show where Mark S. Nestor may publish in the future.

Co-authorship network of co-authors of Mark S. Nestor

This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Nestor. A scholar is included among the top collaborators of Mark S. Nestor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Nestor. Mark S. Nestor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pavicic, Tatjana, et al.. (2025). Aesthetic Improvements Over Time: Long‐Term Efficacy and Additional Outcomes of IncobotulinumtoxinA in the Simultaneous Treatment of Upper Facial Lines. Journal of Cosmetic Dermatology. 24(9). e70460–e70460.

Nestor, Mark S., et al.. (2025). The Use of Light‐Based Therapies in the Treatment of Alopecia. Journal of Cosmetic Dermatology. 24(9). e70434–e70434.

Ståhl, Ulf, et al.. (2025). RelabotulinumtoxinA, a Ready-to-Use Formulation Neuromodulator Manufactured with PEARL™ Technology to Maintain High Biological and Specific Activity. Toxins. 17(10). 501–501.

Lain, Edward, Kenneth Beer, Joely Kaufman, et al.. (2025). 61656 READY-4: Long-term safety with repeated injections using RelabotulinumtoxinA, a novel liquid formulation botulinum toxin, in the treatment of glabellar and lateral canthal lines. Journal of the American Academy of Dermatology. 93(3). AB282–AB282. 1 indexed citations

Chaudry, A, et al.. (2025). Ratio of Nonmelanoma Skin Cancer Histologic Subtypes in a South Florida Dermatology Practice: High Incidence of Squamous Cell Carcinoma Subtypes. SKIN The Journal of Cutaneous Medicine. 9(2). s571–s571.

Bertucci, Vince, Joel Schlessinger, John Joseph, et al.. (2024). Efficacy and Safety of a Novel Formulation Liquid Botulinum Toxin, RelabotulinumtoxinA, When used for Combination Treatment of Glabellar and Lateral Canthal Lines. Toxicon. 237. 107369–107369. 1 indexed citations

Gold, Michael H., Susan C. Taylor, Daniel S. Mueller, et al.. (2024). Efficacy and Safety of LetibotulinumtoxinA in the Treatment of Moderate and Severe Glabellar Lines in Females 35 to 50 Years of Age: Post Hoc Analyses of the Phase 3 Clinical Study Data. SHILAP Revista de lepidopterología. 6. ojae010–ojae010. 3 indexed citations

Goldberg, David J., et al.. (2024). A review of nonsurgical facial rejuvenation and the role of oxymetazoline hydrochloride ophthalmic solution, 0.1% in periorbital revitalization. Journal of Cosmetic Dermatology. 23(4). 1122–1130.

Nestor, Mark S., et al.. (2024). Superficial radiation therapy in dermatology: A historical perspective. 5(3).

10.

Berman, Brian, Seemal R. Desai, Aaron S. Farberg, et al.. (2024). Advances in Technology for Melanoma Diagnosis and Prognosis: An Expert Consensus Panel. Journal of Drugs in Dermatology. 23(9). 774–781. 1 indexed citations

11.

Hetzel, J., et al.. (2024). A cross‐sectional content quality analysis of information in TikTok videos on “Dermarolling (Roller Microneedling)”. Journal of Cosmetic Dermatology. 23(9). 2996–2999. 1 indexed citations

12.

Hetzel, J., et al.. (2023). Cryolipolysis in the United States—Review of the clinical data. Journal of Cosmetic Dermatology. 22(S3). 8–14. 4 indexed citations

13.

Nestor, Mark S., et al.. (2023). Evaluating the safety and efficacy of aminolevulinic acid 20% topical solution activated by pulsed dye laser and blue light in the treatment of facial cutaneous squamous cell carcinoma in situ. Journal of Cosmetic Dermatology. 22(9). 2471–2475. 5 indexed citations

14.

Han, Haowei, et al.. (2022). Superficial radiation therapy for nonmelanoma skin cancer: A review. 3(6). 409–417. 5 indexed citations

15.

Adelglass, Jeffrey, Rui L. Avelar, Leslie Baumann, et al.. (2021). The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients. Aesthetic Surgery Journal. 41(12). 1423–1438. 6 indexed citations

16.

Nahai, Foad, Zbigniew Lorenc, Jeffrey M. Kenkel, et al.. (2013). IncobotulinumtoxinA (Xeomin). Aesthetic Surgery Journal. 33(1_Supplement). 18S–22S. 12 indexed citations

17.

Nahai, Foad, Zbigniew Lorenc, Jeffrey M. Kenkel, et al.. (2013). A Review of AbobotulinumtoxinA (Dysport). Aesthetic Surgery Journal. 33(1_Supplement). 13S–17S. 15 indexed citations

18.

Hanke, C. William, Rhoda S. Narins, Fredric S Brandt, et al.. (2013). A Randomized, Placebo-Controlled, Double-Blind Phase III Trial Investigating the Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Glabellar Frown Lines Using a Stringent Composite Endpoint. Dermatologic Surgery. 39(6). 891–899. 44 indexed citations

19.

Lorenc, Z. Paul, Stacy Smith, Mark S. Nestor, Diane B. Nelson, & Amir Moradi. (2013). Understanding the Functional Anatomy of the Frontalis and Glabellar Complex for Optimal Aesthetic Botulinum Toxin Type A Therapy. Aesthetic Plastic Surgery. 37(5). 975–983. 66 indexed citations

20.

Nestor, Mark S.. (2007). The Use of Photodynamic Therapy for Treatment of Acne Vulgaris. Dermatologic Clinics. 25(1). 47–57. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact